公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 PHADIA DIAGNOSTICOS LTDA取消

340 记录

产品持有公司班级有效性
LDH (IFCC)80254180432PHADIA DIAGNOSTICOS LTDAII现有
Triglycerides80254180433PHADIA DIAGNOSTICOS LTDAII现有
LDL Cholesterol80254180434PHADIA DIAGNOSTICOS LTDAII现有
ALT/GPT (IFCC)80254180437PHADIA DIAGNOSTICOS LTDAII现有
Uric Acid (AOX)80254180438PHADIA DIAGNOSTICOS LTDAII现有
Total Protein Plus80254180439PHADIA DIAGNOSTICOS LTDAII现有
Phosphorus80254180440PHADIA DIAGNOSTICOS LTDAII现有
Pyridoxal Phosphate80254180441PHADIA DIAGNOSTICOS LTDAII现有
Gamma-GT (IFCC)80254180442PHADIA DIAGNOSTICOS LTDAII现有
Família sTfR (Soluble Transferrin Receptor)80254180443PHADIA DIAGNOSTICOS LTDAII现有
Specical80254180444PHADIA DIAGNOSTICOS LTDAII现有
Família HbA1c Hemolyzing Liquids80254180445PHADIA DIAGNOSTICOS LTDAI现有
Complement C480254180446PHADIA DIAGNOSTICOS LTDAII现有
Complement C380254180447PHADIA DIAGNOSTICOS LTDAII现有
Immunoglobulin M80254180448PHADIA DIAGNOSTICOS LTDAII现有
Immunoglobulin G80254180449PHADIA DIAGNOSTICOS LTDAII现有
Immunoglobulin A80254180450PHADIA DIAGNOSTICOS LTDAII现有
HDL Cholesterol80254180451PHADIA DIAGNOSTICOS LTDAII现有
Urea80254180452PHADIA DIAGNOSTICOS LTDAII现有
Magnesium80254180453PHADIA DIAGNOSTICOS LTDAII现有
Rheumatoid Factors 2 (RF 2)80254180454PHADIA DIAGNOSTICOS LTDAII现有
Transferrin80254180455PHADIA DIAGNOSTICOS LTDAII现有
CK-MB80254180456PHADIA DIAGNOSTICOS LTDAIII21/11/2032
Família D-Dimer80254180457PHADIA DIAGNOSTICOS LTDAIII21/11/2032
CEDIA Phenobarbital II Assay80254180458PHADIA DIAGNOSTICOS LTDAIII26/06/2033

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家